Mariannita Gelsomino, Simona Barni, Francesco Mastellone, Giulia Bersani, Marta Barbato, Chiara Condemi, Francesca Mori, Marta Vazquez-Ortiz, Giovanni Cosimo Indirli, Bruno Miceli Sopo, Giovanni Simeone, Stefano Miceli Sopo
{"title":"儿童食物蛋白性小肠结肠炎综合征(FPIES)复发的严重程度趋势。","authors":"Mariannita Gelsomino, Simona Barni, Francesco Mastellone, Giulia Bersani, Marta Barbato, Chiara Condemi, Francesca Mori, Marta Vazquez-Ortiz, Giovanni Cosimo Indirli, Bruno Miceli Sopo, Giovanni Simeone, Stefano Miceli Sopo","doi":"10.1016/j.jaip.2025.01.011","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reintroduction of the offending food in pediatric patients affected by food protein-induced enterocolitis syndrome (FPIES) is carried out in hospitals with an oral food challenge (OFC), which leads to a long waiting time and increases the societal burden of medical cost and human resources.</p><p><strong>Objective: </strong>To assess the severity trend of acute FPIES adverse reactions over time in the same patient for possible outpatient or home reintroduction of the offending food.</p><p><strong>Methods: </strong>All children (aged <18 years) with a diagnosis of acute FPIES referred to two Italian pediatric allergy clinics were retrospectively enrolled. To determine whether home or outpatient clinic reintroduction of trigger food was possible, a risk of severe reactions of 5% or less was arbitrarily considered acceptable.</p><p><strong>Results: </strong>Of202 patients enrolled, 23 (11.4%) had increasing severity from mild to moderate up to severe episodes. No variables analyzed in these patients (sex, age at onset, and the interval between the first and severe episodes) had a statistically significant influence on the risk of more severe reactions. Of all patients who initially presented with mild or moderate episodes, 15.2% and 13.9% later manifested severe episodes over time, respectively. Of patients with cow's milk FPIES that started with a mild episode, 5.5% later experienced a severe episode.</p><p><strong>Conclusions: </strong>Performing OFC for acute FPIES is not safe enough at home because the probability of severe adverse reaction is greater than 5%. However, it could be considered to perform OFC in an outpatient clinic in patients with cow's milk FPIES who started with a mild episode and if a rapid transfer plan to emergency department is available.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome.\",\"authors\":\"Mariannita Gelsomino, Simona Barni, Francesco Mastellone, Giulia Bersani, Marta Barbato, Chiara Condemi, Francesca Mori, Marta Vazquez-Ortiz, Giovanni Cosimo Indirli, Bruno Miceli Sopo, Giovanni Simeone, Stefano Miceli Sopo\",\"doi\":\"10.1016/j.jaip.2025.01.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Reintroduction of the offending food in pediatric patients affected by food protein-induced enterocolitis syndrome (FPIES) is carried out in hospitals with an oral food challenge (OFC), which leads to a long waiting time and increases the societal burden of medical cost and human resources.</p><p><strong>Objective: </strong>To assess the severity trend of acute FPIES adverse reactions over time in the same patient for possible outpatient or home reintroduction of the offending food.</p><p><strong>Methods: </strong>All children (aged <18 years) with a diagnosis of acute FPIES referred to two Italian pediatric allergy clinics were retrospectively enrolled. To determine whether home or outpatient clinic reintroduction of trigger food was possible, a risk of severe reactions of 5% or less was arbitrarily considered acceptable.</p><p><strong>Results: </strong>Of202 patients enrolled, 23 (11.4%) had increasing severity from mild to moderate up to severe episodes. No variables analyzed in these patients (sex, age at onset, and the interval between the first and severe episodes) had a statistically significant influence on the risk of more severe reactions. Of all patients who initially presented with mild or moderate episodes, 15.2% and 13.9% later manifested severe episodes over time, respectively. Of patients with cow's milk FPIES that started with a mild episode, 5.5% later experienced a severe episode.</p><p><strong>Conclusions: </strong>Performing OFC for acute FPIES is not safe enough at home because the probability of severe adverse reaction is greater than 5%. However, it could be considered to perform OFC in an outpatient clinic in patients with cow's milk FPIES who started with a mild episode and if a rapid transfer plan to emergency department is available.</p>\",\"PeriodicalId\":51323,\"journal\":{\"name\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2025-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Allergy and Clinical Immunology-In Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jaip.2025.01.011\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2025.01.011","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome.
Background: Reintroduction of the offending food in pediatric patients affected by food protein-induced enterocolitis syndrome (FPIES) is carried out in hospitals with an oral food challenge (OFC), which leads to a long waiting time and increases the societal burden of medical cost and human resources.
Objective: To assess the severity trend of acute FPIES adverse reactions over time in the same patient for possible outpatient or home reintroduction of the offending food.
Methods: All children (aged <18 years) with a diagnosis of acute FPIES referred to two Italian pediatric allergy clinics were retrospectively enrolled. To determine whether home or outpatient clinic reintroduction of trigger food was possible, a risk of severe reactions of 5% or less was arbitrarily considered acceptable.
Results: Of202 patients enrolled, 23 (11.4%) had increasing severity from mild to moderate up to severe episodes. No variables analyzed in these patients (sex, age at onset, and the interval between the first and severe episodes) had a statistically significant influence on the risk of more severe reactions. Of all patients who initially presented with mild or moderate episodes, 15.2% and 13.9% later manifested severe episodes over time, respectively. Of patients with cow's milk FPIES that started with a mild episode, 5.5% later experienced a severe episode.
Conclusions: Performing OFC for acute FPIES is not safe enough at home because the probability of severe adverse reaction is greater than 5%. However, it could be considered to perform OFC in an outpatient clinic in patients with cow's milk FPIES who started with a mild episode and if a rapid transfer plan to emergency department is available.
期刊介绍:
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.